Tumor-associated macrophages and neutrophils in tumor microenvironment

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Kim, Jaehong ^a   Bae, Jong Sup ^b  

^a Gachon University College of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ACTIVATION; CELL INTERACTION; EXTRACELLULAR TRAP; HUMAN; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ASSOCIATED MYELOID CELL; TUMOR ASSOCIATED NEUTROPHIL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; IMMUNOLOGY; MACROPHAGE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

ANIMALS; HUMANS; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHIL INFILTRATION; NEUTROPHILS; TUMOR MICROENVIRONMENT;

EID: 84959017953     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/6058147     Document Type: Review

References (106)

1. D. Hanahan and R. A.Weinberg, " Hallmarks of cancer: the next generation," Cell, vol. 144, no. 5, pp. 646-674, 2011.
2. J.Wels, R. N. Kaplan, S. Rafii, and D. Lyden, " Migratory neighbors and distant invaders: tumor-Associated niche cells," Genes and Development, vol. 22, no. 5, pp. 559-574, 2008.
3. N. Rezaei, Cancer Immunology: A Translational Medicine Context, Springer, Berlin, Germany, 2015.
4. E. Van Overmeire, D. Laoui, J. Keirsse, J. A. Van Ginderachter, and A. Sarukhan, " Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues," Frontiers in Immunology, vol. 5, article 127, 2014.
5. B.-Z. Qian and J. W. Pollard, " Macrophage diversity enhances tumor progression and metastasis," Cell, vol. 141, no. 1, pp. 39-51, 2010.
6. E. Tu, P. Z. C. Chia, andW. Chen, " TGF in T cell biology and tumor immunity: angel or devil?" Cytokine and Growth Factor Reviews, vol. 25, no. 4, pp. 423-435, 2014.
7. P. M. A. Kelly, R. S. Davison, E. Bliss, and J. O. McGee, " Macrophages in human breast disease: a quantitative immunohistochemical study," British Journal of Cancer, vol. 57, no. 2, pp. 174-177, 1988.
8. L. Bingle, N. J. Brown, and C. E. Lewis, " The role of tumourassociated macrophages in tumour progression: implications for new anticancer therapies," Journal of Pathology, vol. 196, no. 3, pp. 254-265, 2002.
9. Q.-W. Zhang, L. Liu, C.-Y. Gong et al., " Prognostic significance of tumor-Associated macrophages in solid tumor: a metaanalysis of the literature," PLoS ONE, vol. 7, no. 12, Article ID e50946, 2012.
10. P. J. Murray and T. A. Wynn, " Protective and pathogenic functions of macrophage subsets," Nature Reviews Immunology, vol. 11, no. 11, pp. 723-737, 2011.
11. T. E. Rohan, X. Xue, H.-M. Lin et al., " Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer," Journal of the National Cancer Institute, vol. 106, no. 8, Article ID dju136, 2014.
12. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, " Cancerrelated inflammation," Nature, vol. 454, no. 7203, pp. 436-444, 2008.
13. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, " Macrophage polarization: tumor-Associated macrophages as a paradigmfor polarizedM2mononuclear phagocytes," Trends in Immunology, vol. 23, no. 11, pp. 549-555, 2002.
14. S. Gordon and P. R. Taylor, " Monocyte and macrophage heterogeneity," Nature Reviews Immunology, vol. 5, no. 12, pp. 953-964, 2005.
15. Y.-C. Wang, F. He, F. Feng et al., " Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses," Cancer Research, vol. 70, no. 12, pp. 4840-4849, 2010.
16. A.Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati, " The chemokine systemin diverse forms ofmacrophage activation and polarization," Trends in Immunology, vol. 25, no. 12, pp. 677-686, 2004.
17. A. Sica and A.Mantovani, " Macrophage plasticity and polarization: in vivo veritas," The Journal of Clinical Investigation, vol. 122, no. 3, pp. 787-795, 2012.
18. F. Rae, K. Woods, T. Sasmono et al., " Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter," Developmental Biology, vol. 308, no. 1, pp. 232-246, 2007.
19. P. J. Murray, J. E. Allen, S. K. Biswas et al., " Macrophage activation and polarization: nomenclature and experimental guidelines," Immunity, vol. 41, no. 1, pp. 14-20, 2014.
20. A. Sica, P. Larghi, A. Mancino et al., " Macrophage polarization in tumour progression," Seminars in Cancer Biology, vol. 18, no. 5, pp. 349-355, 2008.
21. A. Sica, A. Saccani, B. Bottazzi et al., " Autocrine production of IL-10mediates defective IL-12 production and NF-B activation in tumor-Associated macrophages," The Journal of Immunology, vol. 164, no. 2, pp. 762-767, 2000.
22. D. Moussai, H. Mitsui, J. S. Pettersen et al., " The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-Derived VEGF-C," The Journal of Investigative Dermatology, vol. 131, no. 1, pp. 229-236, 2011.
23. C. Aspord, A. Pedroza-Gonzalez, M. Gallegos et al., " Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development," The Journal of Experimental Medicine, vol. 204, no. 5, pp. 1037-1047, 2007.
24. J. Bollrath and F. R. Greten, " IKK/NF-B and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion andmetastasis," EMBO Reports, vol. 10, no. 12, pp. 1314-1319, 2009.
25. A. Fukuda, S. C.Wang, J.P.Morris et al., " Stat3 andMMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression," Cancer Cell, vol. 19, no. 4, pp. 441-455, 2011.
26. A.Mantovani, " Macrophages, neutrophils, and cancer: a double edged sword," New Journal of Science, vol. 2014, Article ID 271940, 14 pages, 2014.
27. J. Xue, S. V. Schmidt, J. Sander et al., " Transcriptome-based network analysis reveals a spectrum model of human macrophage activation," Immunity, vol. 40, no. 2, pp. 274-288, 2014.
28. D. Laoui, E. Van Overmeire, K. Movahedi et al., " Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site," Immunobiology, vol. 216, no. 11, pp. 1192-1202, 2011.
29. E. Schouppe, P. De Baetselier, J. A. Van Ginderachter, and A. Sarukhan, " Instruction of myeloid cells by the tumor microenvironment: open questions on the dynamics and plasticity of different tumor-Associated myeloid cell populations," OncoImmunology, vol. 1, no. 7, pp. 1135-1145, 2012.
30. A. Casazza, D. Laoui, M. Wenes et al., " Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity," Cancer Cell, vol. 24, no. 6, pp. 695-709, 2013.
31. K. Movahedi, D. Laoui, C. Gysemans et al., " Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes," Cancer Research, vol. 70, no. 14, pp. 5728-5739, 2010.
32. B.Ruffell, N. I. Affara, and L.M.Coussens, " Differential macrophage programming in the tumor microenvironment," Trends in Immunology, vol. 33, no. 3, pp. 119-126, 2012.
33. S. B. Coffelt, C. E. Lewis, L.Naldini, J.M. Brown,N. Ferrara, and M.De Palma, " Elusive identities and overlapping phenotypes of proangiogenicmyeloid cells in tumors,?TheAmerican Journal of Pathology, vol. 176, no. 4, pp. 1564-1576, 2010.
34. A. E. M. Dirkx, M. G. A. Oude Egbrink, J. Wagstaff, and A. W. Griffioen, " Monocyte/macrophage infiltration in tumors: modulators of angiogenesis," Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1183-1196, 2006.
35. D. Duluc, M. Corvaisier, S. Blanchard et al., " Interferon- reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-Associated macrophages," International Journal of Cancer, vol. 125, no. 2, pp. 367-373, 2009.
36. M. De Palma, R. Mazzieri, L. S. Politi et al., " Tumor-Targeted interferon-Alpha delivery by Tie2-Expressing monocytes inhibits tumor growth and metastasis," Cancer Cell, vol. 14, no. 4, pp. 299-311, 2008.
37. R. Ostuni, V. Piccolo, I. Barozzi et al., " Latent enhancers activated by stimulation in differentiated cells," Cell, vol. 152, no. 1-2, pp. 157-171, 2013.
38. Y. Okabe and R. Medzhitov, " Tissue-specific signals control reversible program of localization and functional polarization of macrophages," Cell, vol. 157, no. 4, pp. 832-844, 2014.
39. M. Rosas, L. C. Davies, P. J. Giles et al., " The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal," Science, vol. 344, no. 6184, pp. 645-648, 2014.
40. E. Bonavita, S. Gentile, M. Rubino et al., " PTX3 is an extrinsic oncosuppressor regulating complement-Dependent inflammation in cancer," Cell, vol. 160, no. 4, pp. 700-714, 2015.
41. R.Noy and J.W. Pollard, " Tumor-Associatedmacrophages: from mechanisms to therapy," Immunity, vol. 41,no. 1, pp.49-61, 2014.
42. P. Weitzenfeld and A. Ben-Baruch, " The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer," Cancer Letters, vol. 352, no. 1, pp. 36-53, 2014.
43. J.W. Pollard, " Tumour-Educated macrophages promote tumour progression and metastasis," Nature Reviews Cancer, vol. 4, no. 1, pp. 71-78, 2004.
44. E. Van Overmeire, D. Laoui, J. Keirsse, S. Bonelli, Q. Lahmar, and J. A. Van Ginderachter, " STAT of the union: dynamics of distinct tumor-Associated macrophage subsets governed by STAT1," European Journal of Immunology, vol. 44, no. 8, pp. 2238-2242, 2014.
45. P. Tymoszuk, H. Evens, V. Marzola et al., " In situ proliferation contributes to accumulation of tumor-Associated macrophages in spontaneous mammary tumors," European Journal of Immunology, vol. 44, no. 8, pp. 2247-2262, 2014.
46. R. A. Franklin, W. Liao, A. Sarkar et al., " The cellular and molecular origin of tumor-Associated macrophages," Science, vol. 344, no. 6186, pp. 921-925, 2014.
47. F.H.W. Shand, S. Ueha,M.Otsuji et al., " Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 21, pp. 7771-7776, 2014.
48. E. Van Overmeire, B. Stijlemans, F. Heymann et al., " M-CSF and GM-CSF receptor signaling differentially regulate monocyte maturation and macrophage polarization in the tumor microenvironment," Cancer Research, vol. 76, no. 1, pp. 35-42, 2016.
49. V. Cortez-Retamozo, M. Etzrodt, A. Newton et al., " Origins of tumor-Associated macrophages and neutrophils," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 7, pp. 2491-2496, 2012.
50. A. Mantovani, M. A. Cassatella, C. Costantini, and S. Jaillon, " Neutrophils in the activation and regulation of innate and adaptive immunity," Nature Reviews Immunology, vol. 11, no. 8, pp. 519-531, 2011.
51. S.Nagaraj, A. G. Schrum, H.-I. Cho, E. Celis, andD. I.Gabrilovich, " Mechanism of T cell tolerance induced bymyeloid-Derived suppressor cells," The Journal of Immunology, vol. 184, no. 6, pp. 3106-3116, 2010.
52. Y. Tsuda, H. Takahashi, M. Kobayashi, T. Hanafusa, D. N. Herndon, and F. Suzuki, " Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus," Immunity, vol. 21, no. 2, pp. 215-226, 2004.
53. H. Kolarova, A. Klinke, S. Kremserova et al., " Myeloperoxidase induces the priming of platelets," Free Radical Biology and Medicine, vol. 61, pp. 357-369, 2013.
54. M. Ishizuka, H. Nagata, K. Takagi, Y. Iwasaki, and K. Kubota, " Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer," British Journal of Cancer, vol. 109, no. 2, pp. 401-407, 2013.
55. I.Mishalian, R. Bayuh, L. Levy, L. Zolotarov, J.Michaeli, and Z. G. Fridlender, " Tumor-Associated neutrophils (TAN) develop pro-Tumorigenic properties during tumor progression," Cancer Immunology, Immunotherapy, vol. 62,no. 11,pp. 1745-1756, 2013.
56. J. Jablonska, S. Leschner, K. Westphal, S. Lienenklaus, and S. Weiss, " Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model," The Journal of Clinical Investigation, vol. 120, no. 4,pp. 1151-1164, 2010.
57. F. Donskov, " Immunomonitoring and prognostic relevance of neutrophils in clinical trials," Seminars in Cancer Biology, vol. 23, no. 3, pp. 200-207, 2013.
58. Z. G. Fridlender, J. Sun, I.Mishalian et al., " Transcriptomic analysis comparing tumor-Associated neutrophils with granulocytic myeloid-Derived suppressor cells and normal neutrophils," PLoS ONE, vol. 7, no. 2,Article ID e31524, 2012.
59. A. D. Gregory and A. M. Houghton, " Tumor-Associated neutrophils: new targets for cancer therapy," Cancer Research, vol. 71, no. 7, pp. 2411-2416, 2011.
60. X. Zhang, Q. Zhu, X. Yuan, H. Qian, andW. Xu, " Mesenchymal stem cells in cancer: a new link to neutrophils," Cancer Cell & Microenvironment, vol. 1, no. 3, 2014.
61. I. Mishalian, R. Bayuh, E. Eruslanov et al., " Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17-A new mechanism of impaired antitumor immunity," International Journal of Cancer, vol. 135, no. 5, pp. 1178-1186, 2014.
62. H. Piccard, R. J. Muschel, and G. Opdenakker, " On the dual roles and polarized phenotypes of neutrophils in tumor development and progression," Critical Reviews in Oncology/ Hematology, vol. 82, no. 3, pp. 296-309, 2012.
63. Z. G. Fridlender, J. Sun, S. Kim et al., " Polarization of tumorassociated neutrophil phenotype by TGF-beta: ?N1? versus ?N2? TAN," Cancer Cell, vol. 16, no. 3, pp. 183-194, 2009.
64. V. Kumar and A. Sharma, " Neutrophils: Cinderella of innate immune system," International Immunopharmacology, vol. 10, no. 11, pp. 1325-1334, 2010.
65. D. L. Lefkowitz and S. S. Lefkowitz, " Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited," Immunology and Cell Biology, vol. 79, no. 5, pp. 502-506, 2001.
66. J. Sun, Y. Mao, Y.-Q. Zhang et al., " Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer," Oncology Letters, vol. 6, no. 5, pp. 1253-1260, 2013.
67. R. A. Droeser, C. Hirt, S. Eppenberger-Castori et al., " High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor," PLoS ONE, vol. 8, no. 5, Article IDe64814, 2013.
68. A. L. Rymaszewski, E. Tate, J. P. Yimbesalu et al., " The role of neutrophil myeloperoxidase in models of lung tumor development," Cancers, vol. 6, no. 2, pp. 1111-1127, 2014.
69. V. Brinkmann, U. Reichard, C. Goosmann et al., " Neutrophil extracellular traps kill bacteria," Science, vol. 303, no. 5663, pp. 1532-1535, 2004.
70. H.L.Wright, R. J.Moots, andS.W.Edwards, " Themultifactorial role of neutrophils in rheumatoid arthritis," Nature Reviews Rheumatology, vol. 10, no. 10, pp. 593-601, 2014.
71. G. S. Garcia-Romo, S.Caielli, B.Vega et al., " Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus," Science Translational Medicine, vol. 3, no. 73, Article ID 73ra20, 2011.
72. R. Lande, D. Ganguly, V. Facchinetti et al., " Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus," Science Translational Medicine, vol. 3, no. 73, Article ID73ra19, 2011.
73. R. Khandpur, C. Carmona-Rivera, A. Vivekanandan-Giri et al., " NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis," Science Translational Medicine, vol. 5, no. 178,Article ID 178ra40, 2013.
74. J. Cools-Lartigue, J. Spicer, B. McDonald et al., " Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis," The Journal of Clinical Investigation, vol. 123, no. 8, pp. 3446-3458, 2013.
75. S. Sangaletti, C. Tripodo, C. Vitali et al., " Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphomas," Cancer Discovery, vol. 4, no. 1, pp. 110-129, 2014.
76. J. S. Knight, C. Carmona-Rivera, and M. J. Kaplan, " Proteins derived from neutrophil extracellular traps may serve as selfantigens and mediate organ damage in autoimmune diseases," Frontiers in Immunology, vol. 3, article 380, 2012.
77. J. Cools-Lartigue, J. Spicer, S. Najmeh, and L. Ferri, " Neutrophil extracellular traps in cancer progression," Cellular and Molecular Life Sciences, vol. 71, no. 21, pp. 4179-4194, 2014.
78. S. Berger-Achituv, V. Brinkmann, U. A. Abed et al., " A proposed role for neutrophil extracellular traps in cancer immunoediting," Frontiers in Immunology, vol. 4, article 48, 2013.
79. E. B. Eruslanov, P. S. Bhojnagarwala, J. G. Quatromoni et al., " Tumor-Associated neutrophils stimulate T cell responses in early-stage human lung cancer," The Journal of Clinical Investigation, vol. 124, no. 12, pp. 5466-5480, 2014.
80. N. M. Bambace and C. E. Holmes, " The platelet contribution to cancer progression," Journal of Thrombosis and Haemostasis, vol. 9, no. 2, pp. 237-249, 2011.
81. L. J. Gay and B. Felding-Habermann, " Contribution of platelets to tumour metastasis," Nature Reviews Cancer, vol. 11, no. 2, pp. 123-134, 2011.
82. P. Jurasz, D. Alonso-Escolano, and M. W. Radomski, " Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation," British Journal of Pharmacology, vol. 143, no. 7, pp. 819-826, 2004.
83. J. A. Joyce and J.W. Pollard, " Microenvironmental regulation of metastasis," Nature Reviews Cancer, vol. 9, no. 4, pp. 239-252, 2009.
84. S. Taucher, A. Salat, M. Gnant et al., " Impact of pretreatment thrombocytosis on survival in primary breast cancer," Thrombosis and Haemostasis, vol. 89, no. 6, pp. 1098-1106, 2003.
85. E. Sierko and M. Z. Wojtukiewicz, " Platelets and angiogenesis in malignancy," Seminars inThrombosis and Hemostasis, vol. 30, no. 1, pp. 95-108, 2004.
86. H.-G. Kopp and S. Rafii, " Thrombopoietic cells and the bone marrow vascular niche," Annals of the New York Academy of Sciences, vol. 1106, pp. 175-179, 2007.
87. A. Gros, V. Ollivier, and B. Ho-Tin-Nóe, " Platelets in inflammation: regulation of leukocyte activities and vascular repair," Frontiers in Immunology, vol. 5, article 678, 2014.
88. J. H. Im, W. Fu, H. Wang et al., " Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation," Cancer Research, vol. 64, no. 23, pp. 8613-8619, 2004.
89. J. S. Palumbo, " Mechanisms linking tumor cell-Associated procoagulant function to tumor dissemination," Seminars in Thrombosis and Hemostasis, vol. 34, no. 2, pp. 154-160, 2008.
90. I. Lal, K. Dittus, and C. E. Holmes, " Platelets, coagulation and fibrinolysis in breast cancer progression," Breast Cancer Research, vol. 15, no. 4, article 207, 2013.
91. A. M.Gil-Bernabe, S. FerjaňcѤc, M. Tlalka et al., " Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice," Blood, vol. 119, no. 13, pp. 3164-3175, 2012.
92. M. Labelle, S. Begum, and R. O. Hynes, " Platelets guide the formation of early metastatic niches," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 30, pp. E3053-E3061, 2014.
93. G. L. Beatty, E. G. Chiorean, M. P. Fishman et al., " CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans," Science, vol. 331, no. 6024, pp. 1612-1616, 2011.
94. I. N. Buhtoiarov, P. M. Sondel, J. M. Wigginton et al., " Antitumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumourassociated macrophages," Immunology, vol. 132, no. 2, pp. 226-239, 2011.
95. B.-Z. Qian, J. Li, H. Zhang et al., " CCL2 recruits inflammatory monocytes to facilitate breast-Tumour metastasis," Nature, vol. 475, no. 7355, pp. 222-225, 2011.
96. K. Garber, " First results for agents targeting cancer-related inflammation," Journal of the National Cancer Institute, vol. 101, no. 16, pp. 1110-1112, 2009.
97. G. Germano, R. Frapolli, C. Belgiovine et al., " Role of macrophage targeting in the antitumor activity of trabectedin," Cancer Cell, vol. 23, no. 2, pp. 249-262, 2013.
98. E. Giraudo, M. Inoue, and D. Hanahan, " An amino-bisphosphonate targets MMP-9-Expressing macrophages and angiogenesis to impair cervical carcinogenesis,?The Journal of Clinical Investigation, vol. 114, no. 5, pp. 623-633, 2004.
99. S. M. Zeisberger, B. Odermatt, C. Marty, A. H. M. Zehnder-Fjällman, K. Ballmer-Hofer, and R. A. Schwendener, " Clodronate-liposome-mediated depletion of tumour-Associated macrophages: a new and highly effective antiangiogenic therapy approach," British Journal of Cancer, vol. 95, no. 3, pp. 272-281, 2006.
100. A. M. Houghton, D. M. Rzymkiewicz, H. Ji et al., " Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth," Nature Medicine, vol. 16, no. 2, pp. 219-223, 2010.
101. D. Sharma, K. E. Brummel-Ziedins, B. A. Bouchard, and C. E. Holmes, " Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer," Journal of Cellular Physiology, vol. 229, no. 8, pp. 1005-1015, 2014.
102. J. Tímár, J. Tóvári, E. Rás̈o, L. Mésźaros, B. Bereczky, and K. Lapis, " Platelet-mimicry of cancer cells: epiphenomenon with clinical significance," Oncology, vol. 69, no. 3, pp. 185-201, 2005.
103. A. Stadtmann and A. Zarbock, " CXCR2: from bench to bedside," Frontiers in Immunology, vol. 3, article 263, 2012.
104. H. Ijichi, A. Chytil, A. E. Gorska et al., " Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma," Journal of Clinical Investigation, vol. 121, no. 10, pp. 4106-4117, 2011.
105. H. A. Smith and Y. Kang, " The metastasis-promoting roles of tumor-Associated immune cells," Journal ofMolecularMedicine, vol. 91, no. 4, pp. 411-429, 2013.
106. T. Kitamura, B.-Z. Qian, and J. W. Pollard, " Immune cell promotion of metastasis," Nature Reviews Immunology, vol. 15, no. 2, pp. 73-86, 2015.